Allen Institute for Artificial Intelligence
supp.ai logo
supp.ai

Discover Supplement-Drug Interactions

Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 3 years ago

Possible Interaction: Glycine and L-4-Chlorokynurenine

Research Papers that Mention the Interaction

This effect was prevented by 10 μm 7‐chlorokynurenic acid , an antagonist of the glycine site of the NMDA receptor.
British journal of pharmacology  •  1996  |  View Paper
In addition, 7‐chlorokynurenic acid , an antagonist at the glycine site, is able to reverse the displacement of [3H]CGP 39653 by glycine in a dose‐dependent manner.
Journal of neurochemistry  •  1993  |  View Paper
5 The inhibitory action of 7‐chlorokynurenate and that of CPP on [3H]‐(+)‐MK 801 binding were reversed by addition of glycine and glutamate respectively.
British journal of pharmacology  •  1993  |  View Paper
An … the glycine site, 7‐chlorokynurenic acid (Cl‐Kyn), completely blocked both the short‐term and the long‐term potentiation associated with theta burst stimulation (TBS) linked to … receptor activation in slices from hippocampus at postnatal days 10–16; this effect was reversed by the glycine agonist, d‐serine.
International Journal of Developmental Neuroscience  •  1990  |  View Paper
Putative glycine antagonists HA‐966 and 7‐chlorokynurenic acid were highly effective in preventing NMDA neurotoxicity, even in the absence of added glycine.
The neuroprotective action of HA‐966 and 7‐chlorokynurenic acid , but not that of NMDA antagonists 3‐(2‐carboxypiperazine‐4‐yl)propylphosphonate and MK‐801, could be reversed by glycine.
Journal of neurochemistry  •  1990  |  View Paper
The glycine antagonist 7‐chlorokynurenic acid inhibited the effects of NMDA and this inhibition was reversed by glycine.
Journal of neurochemistry  •  1990  |  View Paper
Thus, 7-Cl-kyn was approximately 40-fold more potent at the glycine site than at the receptor mediating kainate currents but is probably not entirely competitive at the latter receptor.
Molecular pharmacology  •  1989  |  View Paper